| Title |
Targeting Immune Checkpoints in Lung Cancer: Current Landscape and Future Prospects
|
|---|---|
| Published in |
Clinical Drug Investigation, February 2019
|
| DOI | 10.1007/s40261-018-00746-5 |
| Pubmed ID | |
| Authors |
Long Long, Chen Zhao, Muqimova Ozarina, Xianda Zhao, Jing Yang, Honglei Chen |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 44 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 16% |
| Student > Bachelor | 7 | 16% |
| Student > Ph. D. Student | 5 | 11% |
| Student > Doctoral Student | 2 | 5% |
| Professor > Associate Professor | 2 | 5% |
| Other | 4 | 9% |
| Unknown | 17 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 23% |
| Biochemistry, Genetics and Molecular Biology | 5 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Immunology and Microbiology | 2 | 5% |
| Nursing and Health Professions | 1 | 2% |
| Other | 6 | 14% |
| Unknown | 18 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2019.
All research outputs
#18,669,294
of 23,130,383 outputs
Outputs from Clinical Drug Investigation
#824
of 981 outputs
Outputs of similar age
#266,488
of 351,273 outputs
Outputs of similar age from Clinical Drug Investigation
#14
of 21 outputs
Altmetric has tracked 23,130,383 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 981 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,273 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.